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Abstract The neuronal nicotinic acetylcholine receptor 
(nAChR) subunits cr3 and d7 have different assembly behavior 
when expressed in heterologous expression systems: 0.3 subunits 
require other subunits to assemble functional nAChRs, whereas 
a7 subunits can produce homomeric nAChRs. A previous 
analysis of cz7/cr3 chimeric constructs identified a domain 
comprising the first putative membrane-spanning segment, Ml, 
as essential to homomeric assembly. The present study dissected 
further this domain, identifying three amino acid residues, which 
are located at the most intracellular third of the Ml 
transmembrane segment, as important in the assembly of 
homomers. Moreover, formation of homooligomeric complexes 
seems to require a compatible accommodation between this 
region and certain residues of the second transmembrane 
segment, M2. Thus, compatibility between defined domains of 
the Ml and M2 transmembrane segments appears as a 
determinant factor governing homomer association of nAChR 
subunits. 
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1. Introduction 
Neurotransmitter-gated receptors are oligomeric membrane 
proteins composed of homologous subunits (reviewed in 
[1,2]). Different subunit combinations yield different receptor 
subtypes with dissimilar channel properties (reviewed in [3]). 
The neuronal nicotinic acetylcholine receptor (nAChR) family 
is composed of agonist binding (a2-~9) and structural (p2- 
p4) subunits (reviewed in [4]). In heterologous expression sys- 
tems it has been demonstrated that some a subunits (1~2-4) 
need to combine with structural subunits (j32, j34 and, in some 
cases, a5 [5,6]) to form heteromeric functional receptors. 
However, other CL subunits (a7-a9) can form homomeric 
AChRs and do not seem to assemble with the ones which 
form heteromeric nAChRs [7-91. The same situation may 
also occur in vivo, at least for some receptor subtypes. 
Thus, in chick ciliary ganglion cells [ 10,111, bovine chromaffin 
cells [12,13] and the human neuroblastoma SH-SYSY [6] the 
a3 and a7 subunits seem to be components of two different 
receptor subtypes, which suggests that a mechanism may exist, 
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in order to discriminate between these subunits, which are 
structurally similar. 
In a previous analysis, we exploited the aforementioned 
differences between a3 and a7 subunits in multimer assembly 
to demonstrate that a domain, which includes the first puta- 
tive transmembrane segment, Ml, seems essential for homo- 
mer formation [14]. We have now extended further that study 
to show that three amino acids of the Ml segment, located 
close to its cytoplasmic end, determine the formation of 
homomers, probably as a result of compatibility or adaptabil- 
ity with some residues of the M2 transmembrane segment. 
2. Materials and methods 
2.1. Construction of chimeras and point mutants 
Chimeras and point mutations were made essentially as described 
previously [ 151 by performing two successive PCR amplifications [ 141. 
The mutated or chimeric DNA obtained from the second PCR was 
sequenced before being manipulated further with restriction enzymes, 
for insertion into its appropriate location in the original gene. All 
chimeras consist of the N-terminal region of the bovine a7 subunit 
[13], including a short 5’ non-coding region, its leader peptide and 
part of the Ml membrane-spanning segment. The remaining regions 
of each chimera were composed of bovine ct3 [12] or c~7 subunit 
segments, as indicated in each figure legend. 
2.2. Oocyte expression 
Capped mRNA was synthesized in vitro using SP6 RNA polymer- 
ase (Boehringer Mannheim) and template DNAs inserted into pSP64T 
vector [16]. Xenopus (Nasco) oocytes were inoculated with 25 ng of 
RNA in 50 nl of sterile water. Characterization of the resulting 
nAChRs was performed between 3 and 4 days after injection. 
The assembly capacity of each construct was assessed by measuring 
the total surface expression of a-bungarotoxin (a-Bgt)-binding 
nAChRs. Briefly, oocytes were preincubated at 18°C for 30 min in 
Barth’s solution containing 5% fetal calf serum; then a saturating 
concentration (5 nM) of cx-[‘251]Bgt (Amersham) was added, and the 
oocytes were incubated for 2 h at 18°C. The excess toxin was removed 
with five 4-ml washes of Barth’s solution. Non-specific binding was 
determined using non-inoculated oocytes. 
When chimeric constructs were able to produce functional 
nAChRs, oocyte membrane currents were measured with a two-mi- 
croelectrode voltage-clamp amplifier as in [14]. This only applies to 
those constructs which contain the M2-M3 loop of a7 subunit (c~7 
mutants in Fig. 1 and the chimera C41 in Fig. 2), as we have pre- 
viously shown that an Asp residue present in a7 (As~‘~~) and 84 
(Asp2’j8) but not in a3 subunits is essential to couple binding and 
gating in this type of nAChRs [17]. 
3. Results and discussion 
The different assembly behavior shown by certain nAChR 
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Fig. 1. Schematic diagrams and assembly capacity of ct3/a7 constructs and a7 point mutants used to study the role of transmembrane segment 
Ml in homomeric assembly. The amino acid sequence of the Ml region of each chimera (designated C, top), or a7 mutant (a7, bottom) is dis- 
played on the left. Arrowheads indicate the boundary between a7 (N-terminal) and a3 (C-terminal) sequences in the chimeras. Amino acid 
numbering relates to the a7 subunit [13]. Expression of the different constructs was tested by a-Bgt binding. All data were normalized to the 
mean obtained in the same oocyte batch with the a7 subunit alone, and the mean f S.E.M. of at least 20 different oocytes from each of three 
different donors are shown for every construct. Typical values obtained with the a7 subunit were 3-5 fmol bound a-Bgt/oocyte. For the sake 
of brevitv. construct C18. in which the a7 seauence extended UD to Ile x7 has not been included in this figure. This construct did not give rise , 
to assembled nAChRs. 
subunits, such as the a3 and a7 polypeptides, which are ex- 
pressed in the same cell but segregate to form different 
nAChR subtypes has been previously used to establish a mod- 
el system in which to study the regions involved in intersubu- 
nit recognition [14]. Thus, a3/a7 chimeras were constructed 
and their cRNA injected into oocytes to produce homomeric 
nAChRs whose a-Bgt binding capacity was determined. This 
approach allowed us to reinforce and extend previous reports 
indicating the importance of the N-terminal region in inter- 
subunit recognition [l&21 1, and to demonstrate that a short 
domain of 37 amino acids, which includes the first putative 
transmembrane segment Ml, seems essential for homomer 
formation [ 141. 
The present study dissected further this domain by con- 
structing chimeras in which the a3la7 boundary was located 
at positions intermediate between the previous ones shown to 
be able or not to produce homomeric nAChRs (designated C5 
and C3, respectively, in [14]). Since in C3 the a7 sequence 
expanded from the N-terminus to Argzo6 whereas in CS it 
extended further to Leuz4’, intermediate constructs were 
made, in which the a7 sequence extended up to Ile217 (C18), 
Leu225 (C22) and Pro 233 (C19) (see scheme in Fig. 1). The first 
two constructs did not yield homomeric nAChRs whereas Cl9 
produced a-Bgt binding activity close to that observed with 
a7 nAChRs (Fig. 1). As previously discussed [14], the strategy 
of measuring a-Bgt binding sites at the external oocyte mem- 
brane is expected to detect only properly assembled nAChRs 
that have followed an accurate maturation pathway from the 
endoplasmic reticulum to the oocyte plasma membrane [22]. 
In fact, solubilization and further sucrose gradient centrifuga- 
tion of a-Bgt labeled nAChRs present in the external mem- 
brane of the oocytes yielded unique molecular species with a 
size close to that of a Torpedo nAChR composed of the 
a12~l~S combination (not shown). Alternatively, the lack of 
a-Bgt binding could be due to the assembly of chimeric re- 
ceptors unable to bind the toxin. This possibility appears un- 
likely if we consider that Cl9 and C22 differ in only three 
amino acids (Fig. 1) within an area located far away from 
the toxin binding determinants and that the multiplicity of 
contacts between a-toxins and nAChRs results in a very 
strong interaction, which is difficult to distort. In fact, even 
denatured a subunit [23] or synthetic peptides (a186-196) [24] 
are able to bind a-Bgt. It is also important to note that we 
used a7 nAChR expression as an internal control in all ex- 
periments because of the inherent variability of the oocyte 
expression system: the results are expressed as a percentage 
of the a-Bgt binding observed with a7 nAChRs. 
As mentioned above, only three amino acids (positions 226, 
227 and 231) are different between Cl9 and C22, therefore 
they appeared responsible for the different behavior of these 
chimeras and were further mutated in Cl9 to make them 
appear as in C22. Constructs C19T (Ala226Thr) and C19V 
(Leu227Val) resulted in N 50% decrease in homomeric assem- 
bly (Fig. 1) whereas the double mutant C19TV (Ala226Thr; 
Leu227Val) yielded an even larger decrease (13% of the bind- 
ing sites observed with a7 nAChRs). Finally, C19Y 
(Leu231Tyr) was unable to produce homomeric nAChRs 
(Fig. 1). Thus, it was concluded that these three amino acids 
may play an important role in controlling homomeric assem- 
bly. 
The chimeras used were composed of a7 (N-terminus) and 
a3 (C-terminus) sequences and it could happen that some of 
the effects observed in Cl9 mutants could not only be con- 
tributed by the mutated amino acids but also be due to a 
combined effect with some part of the a3 structure. Conse- 
quently, the same mutations were carried out in the wild a7 
sequence and the assembly of the resultant mutants studied 
(Fig. 1, bottom). Two single mutants a7T (Ala2*‘jThr)and 
a7V (Leu227Val) showed a slightly lower degree of assembly 
inhibition than their Cl9 counterparts. However, a7Y 
(Leuz31Tyr) only presented -30% inhibition, in contrast 
with the total inhibition produced by C19Y. Even the double 
mutant a7TY (Ala226Thr; Leuz31Tyr) did not show more than 
-3040% decrease in homomeric assembly. All a7 mutants 
produced functional responses upon activation with nicotine 
(not shown). 
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Fig. 2. Schematic diagrams and assembly capacity of a3/cr7 constructs used to study the interaction of Leu/Tyrs31 with other parts of the a7 
subunit. The structure of each chimera is displayed with empty and filled boxes representing o3 and o7 domains, respectively, whereas Ml, 
M2, M3 and M4 are the membrane-spanning segments. A letter Y over Ml indicates that this construct contains the Leu231Tyr mutation. For 
comparison, Cl9 and C19Y results from the previous figure are included here. Assembly was tested as in Fig. 1. The inset represents the amino 
acid sequence of the M2 region of C42 and C43. Again, a3 and a7 sequences are indicated by open and shaded boxes, respectively. Amino 
acid numbering relates to the ct7 subunit. 
The results obtained with a7 mutants suggested that some 
domain, present in a7 but not in Cl9 and interacting with the 
most intracellular third of the Ml segment, was able to toler- 
ate or accommodate the Leu231Tyr mutation, providing us 
with the opportunity of approaching its identification. The 
strategy followed was to construct chimeras similar to C19Y 
in which certain segments of the a3 subunit had been substi- 
tuted by their a7 equivalent, thus trying to reverse the dele- 
terious effect that the Leuz3rTyr mutation had induced in C19. 
When segments corresponding approximately to transmem- 
brane fragment M4 (Fig. 2, C39) or transmembrane fragment 
M3 and the cytoplasmic loop (Fig. 2, C40) were exchanged, 
no assembly of receptors was observed. By contrast, the in- 
corporation of transmembrane fragment M2 and the loop 
linking it to M3 (i.e. when the a7 sequence continuously ex- 
tended from the N-terminus to Gin’“) restored receptor as- 
sembly (Fig. 2, C41) and functional responses (not shown). 
This domain was further analyzed by including only part of 
transmembrane fragment M2. When the a7 sequence reached 
up to Met254 nAChRs were expressed (Fig. 2, C42), while a 
shorter extension, up to Leu242, produced a lack of assembly 
(Fig. 2, C43). Only three amino acids are distinct when com- 
paring C42 and C43 (see inset in Fig. 2) and, therefore, one or 
several of these residues would conform to the area which 
interacts with Leu/Tyr 231 As this residue should be close to 
the cytoplasmic side of the membrane, whatever the structure 
assumed for the Ml membrane-spanning segment, it is rea- 
sonable to infer that amino acids G1y243 and/or Thr245 in M2 
are the ones interacting with the former, since they are more 
cytoplasmically located than Met254. 
The results obtained in the present report support the idea 
that, in addition to N-terminal domains [14,18-21,25,26], cer- 
tain amino acids in the Ml transmembrane fragment control 
~17 subunit homomeric assembly. Moreover, at least for Leu/ 
Tyrz31, this control seems to be produced by way of its inter- 
action with other amino acids from the M2 segment. As in the 
case of the N-terminal domains mentioned above, the na- 
ture of this interaction is not obvious upon inspecting the 
amino acids involved. Thus, it is tempting to invoke some 
sort of steric complementarity between amino acid chains 
which, given their location in the hydrophobic membrane- 
spanning segments, might be tightly packed. Consequently, 
only compatible residues would allow the assembly of 
nAChRs. 
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